Prophylactic lidocaine for post resuscitation care of patients with out-of-hospital ventricular fibrillation cardiac arrest

Resuscitation

Volumn 84, Issue 11, 2013, Pages 1512-1518

  Kudenchuk, Peter J ^a,c   Newell, Cameron ^b   White, Lindsay ^c   Fahrenbruch, Carol ^c   Rea, Tom ^b,c   Eisenberg, Mickey ^b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Public Health of Seattle and King County   (United States)

Author keywords

Arrhythmia; Cardiac arrest; Lidocaine

Indexed keywords

LIDOCAINE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HEART VENTRICLE FIBRILLATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUT OF HOSPITAL CARDIAC ARREST; PATIENT CARE; PRIORITY JOURNAL; RESUSCITATION; RETURN OF SPONTANEOUS CIRCULATION; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ARRHYTHMIA; CARDIAC ARREST; LIDOCAINE;

AGED; ANTI-ARRHYTHMIA AGENTS; CARDIOPULMONARY RESUSCITATION; EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; LIDOCAINE; MALE; OUT-OF-HOSPITAL CARDIAC ARREST; PATIENT ADMISSION; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; VENTRICULAR FIBRILLATION;

EID: 84886792239     PISSN: 03009572     EISSN: 18731570     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2013.05.022     Document Type: Article

References (39)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2011 update. Circulation 2011, 123:e18-e209.
2. Nichol G., Thomas E., Callaway C.W., et al. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA 2008, 300::1423-1431.
3. Cobb L.A., Fahrenbruch C.E., Olsufka M., Copass M.K. Changing incidence of out-of-hospital ventricular fibrillation 1980-2000. JAMA 2002, 288:3008-3013.
4. Peberdy M.A., Callaway C.W., Neumar R.W., et al. Part 9: post-cardiac arrest care: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2010, 122:S768-S786.
5. White R.D., Russell J.K. Re-fibrillation, resuscitation and survival in out-of-hospital sudden cardiac arrest victims treated with biphasic automated external defibrillators. Resuscitation 2002, 55:17-23.
6. Kudenchuk P.J., Cobb L.A., Copass M.K., Olsufka M., Maynard C., Nichol G. Transthoracic incremental monophasic versus biphasic defibrillation by emergency responders (TIMBER). Circulation 2006, 114:2010-2018.
7. Kudenchuk P.J., Cobb L.A., Copass M.K., et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999, 341:871-878.
8. van Alem A.P., Post J., Koster R.W. VF recurrence: characteristics and patient outcome in out-of-hospital cardiac arrest. Resuscitation 2003, 59:181-188.
9. Koster R.W., Walker R.G., Chapman F.W. Recurrent ventricular fibrillation during advanced life support of patients with prehospital cardiac arrest. Resuscitation 2008, 78:252-257.
10. Herlitz J., Ekström L., Wennerblom B., et al. Lidocaine in out-of-hospital ventricular fibrillation. Does it improve survival?. Resuscitation 1997, 33:199-205.
11. White S.J., Himes D., Rouhani M., Slovis C.M. Selected controversies in cardiopulmonary resuscitation. Semin Respir Crit Care Med 2001, 22:35-50.
12. Gazmuri R.J., Nadkarni V.M., Nolan J.P., et al. Scientific knowledge gaps and clinical research priorities for cardiopulmonary resuscitation and emergency cardiovascular care identified during the 2005 international consensus conference on ECC and CPR science with treatment recommendations. Circulation 2007, 116:2501-2512.
13. American Heart Association in Collaboration with the International Liaison Committee on Resuscitation Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2000, 102:I112-I128.
14. Kudenchuk P.J. Pharmacology in emergency cardiovascular care. The textbook of emergency cardiovascular care and CPR 2009, 379-394. Lippincott Williams and Wilkins, Philadelphia. J.M. Field, P.J. Kudenchuk, R.E. O'Connor (Eds.).
15. Rea T.D., Helbock M., Perry S., et al. Increasing use of cardiopulmonary resuscitation during out-of-hospital ventricular fibrillation arrest: survival implications of guideline changes. Circulation 2006, 114:2760-2765.
16. Idris A.H., Becker L.B., Ornato J.P., et al. Utstein-style guidelines for uniform reporting of laboratory CPR research. Resuscitation 1996, 33:69-84.
17. Rea T.D., Eisenberg M.S., Becker L.J., Murray J.S., Hearne T. Temporal trends in sudden cardiac arrest. Circulation 2003, 107:2780-2785.
18. Austin P.C. Some methods of propensity-score matching had superior performance to others. Biom J 2009, 51:171-184.
19. Harrison E.E. Lidocaine in prehospital countershock refractory ventricular fibrillation. Ann Emerg Med 1981, 10:420-423.
20. Weaver W., Fahrenbruch C., Johnson D., Hallstrom A., Cobb L.A., Copass M.K. Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation. Circulation 1990, 82:2027-2034.
21. van Walraven C.S.I., Wells G., Hebert P., Vandemheen K. Do advanced cardiac life support drugs increase resuscitation rates from in-hospital cardiac arrest?. Ann Emerg Med 1998, 32:544-553.
22. Stiell I.G., Wells G.A., Hebert P.C., Laupacis A., Weitzman B.N. Association of drug therapy with survival in cardiac arrest: limited role of advanced cardiac life support drugs. Acad Emerg Med 1995, 2:264-273.
23. Skrifvars M.B., Pettila V., Rosenberg P.H., Castren M. A multiple logistic regression analysis of in-hospital factors related to survival at six months in patients resuscitated from out-of-hospital ventricular fibrillation. Resuscitation 2003, 59:319-328.
24. Lie K.I., Liem K.L., Louridtz W.J., Janse M.J., Willebrands A.F., Durrer D. Efficacy of lidocaine in preventing primary ventricular fibrillation within 1 hour after a 300mg intramuscular injection. Am J Cardiol 1978, 42:486-488.
25. Lie K.I., Wellens H.J., van Capelle F.J., Durrer D. Lidocaine in the prevention of primary ventricular fibrillation. N Engl J Med 1974, 291:1324-1326.
26. Koster R.W., Dunning A.J. Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospital phase of acute myocardial infarction. N Engl J Med 1985, 313:1105-1110.
27. Sadowski A.P., Alexander J.H., Skrabucha B., et al. Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction. Am Heart J 1999, 137:792-798.
28. Alexander J.H., Granger C.B., Sadowski Z., et al. Prophylactic lidocaine use in acute myocardial infarction. Am Heart J 1999, 137:799-805.
29. DeSilva R.A., Lown B., Hennekens C.H., Casscells W. Lignocaine prophylaxis in acute myocardial infarction: An evaluation of randomized trials. Lancet 1981, 2:855-858.
30. Teo K.K., Yusef S., Furberg C.D. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. JAMA 1993, 270:1589-1595.
31. Prengel A.W., Lindner K.H., Ensinger H., Grunert A. Plasma catecholamine concentrations after successful resuscitation in patients. Crit Care Med 1992, 20:609-614.
32. Lindner K.H., Haak T., Keller A., Bothner U., Lurie K.G. Release of endogenous vasopressors during and after cardiopulmonary resuscitation. Heart 1996, 75:145-150.
33. De Maio V.J., Stiell I.G., Wells G.A., Spaite D.W. Cardiac arrest witnessed by emergency medical services personnel. Ann Emerg Med 2000, 35:138-146.
34. Echt D.S., Liebson P.R., Mitchell L.B., et al. Mortality and morbidity in patients receiving encainide, flecainide or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991, 324:781-788.
35. Hallstrom A.P., Cobb L.A., Swain M., Mensinger K. Predictors of hospital mortality after out-of-hospital cardiopulmonary resuscitation. Crit Care Med 1985, 13:927-929.
36. Nolan P.E. Pharmacokinetics and pharmacodynamics of intravenous agents for ventricular arrhythmias. Pharmacotherapy 1997, 17:65S-75S.
37. Pu J., Balser J.R., Boyden P.A. Lidocaine action on Na+ currents in ventricular myocytes from the epicardial border zone of the infracted heart. Circ Res 1998, 83:431-440.
38. Cushing D.J., Cooper W.D., Grralinski M.R., Lipicky R.J. The hypotensive effect of intravenous amiodarone is sustained throughout the maintenance infusion period. Clin Exp Pharmacol Physiol 2010, 37:58-61.
39. U.S.Food and Drug Administration 21 CFR Part 50.24 Exception from informed consent requirements for emergency research 2012, http://www.fda.gov/oc/ohrt/irbs/appendixb.html [accessed 17.12.12].